You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《公司業績》華潤醫藥(03320.HK)全年純利38.5億人幣升10% 末期息16港仙
阿思達克 03-26 12:12
華潤醫藥(03320.HK)公布截至去年12月底止全年業績。純利38.54億元人民幣(下同),按年升10.1%;每股盈利0.61元。派末期息16港仙,與上年同期相同。 期內,集團營業額2,447.04億元,按年升12.2%。 當中製藥、醫藥分銷、藥品零售三個主要業務分部的收益佔比分別為16.0%、80.0%以及3.9%。另外,集團毛利383.37億元,按年升14%。整體毛利率15.7%,按年提高0.3個百分點,公司解釋主要受惠於期內製藥業務毛利率水平提升所帶動。(js/k) ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account